(136b) A New Approach in Applying CSP for the Pharmaceutical Industry

Authors: 
Jiang, A., XtalPi Inc.
Wen, S., XtalPi Inc.
The ability to solve solid-state structures through organic crystal structure prediction (CSP) has remained elusive despite many years of industry and academic research. More recently, however, advances in computer technology and modeling have combined to rekindle enthusiasm for CSP. The pharmaceutical industry is particularly interested in CSP due to the importance of solid-state structures and properties in the drug development process. Real-time applications of several CSP technologies are currently at the proof-of-concept stage.

XtalPi, the industry pioneer in innovative CSP technology, deploys an advanced algorithm platform as part of its intelligent digital solid-state prediction technology. The XtalPi CSP technology has emerged from proof-of-concept through rigorous and extensive internal and external challenges, and is particularly well suited for the pharmaceutical industry. Indeed, XtalPi has already integrated its CSP technology into drug design and pharmaceutical product development in collaboration with industry partners.


Checkout

This paper has an Extended Abstract file available; you must purchase the conference proceedings to access it.

Checkout

Do you already own this?

Pricing


Individuals

2017 Annual Meeting
AIChE Members $150.00
AIChE Graduate Student Members Free
AIChE Undergraduate Student Members Free
Non-Members $225.00
Pharmaceutical Discovery, Development and Manufacturing Forum only
AIChE Members $100.00
AIChE Food, Pharmaceutical & Bioengineering Division Members Free
AIChE Graduate Student Members Free
AIChE Undergraduate Student Members Free
Non-Members $150.00